• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发现具有δ/μ阿片受体激动剂和神经激肽1受体拮抗剂活性的三肽衍生多功能配体。

Discovery of tripeptide-derived multifunctional ligands possessing delta/mu opioid receptor agonist and neurokinin 1 receptor antagonist activities.

作者信息

Nair Padma, Yamamoto Takashi, Cowell Scott, Kulkarni Vinod, Moye Sharif, Navratilova Edita, Davis Peg, Ma Shou-Wu, Vanderah Todd W, Lai Josephine, Porreca Frank, Hruby Victor J

机构信息

Department of Chemistry and Biochemistry, University of Arizona, 1306 East University Boulevard, Tucson, AZ 85721, USA.

Department of Pharmacology, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ 85724, USA.

出版信息

Bioorg Med Chem Lett. 2015 Sep 1;25(17):3716-20. doi: 10.1016/j.bmcl.2015.06.030. Epub 2015 Jun 15.

DOI:10.1016/j.bmcl.2015.06.030
PMID:26212775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4642890/
Abstract

Several bifunctional peptides were synthesized and characterized based on the pentapeptide-derived ligand NP30 (1: Tyr-DAla-Gly-Phe-Gly-Trp-O-[3',5'-Bzl(CF3)2]). Modification and truncation of amino acid residues were performed, and the tripeptide-derived ligand NP66 (11: Dmt-DAla-Trp-NH-[3',5'-(CF3)2-Bzl]) was obtained based on the overlapping pharmacophore concept. The Trp(3) residue of ligand 11 works as a message residue for both opioid and NK1 activities. The significance lies in the observation that the approach of appropriate truncation of peptide sequence could lead to a tripeptide-derived chimeric ligand with effective binding and functional activities for both mu and delta opioid and NK1 receptors with agonist activities at mu and delta opioid and antagonist activity at NK1 receptors, respectively.

摘要

基于五肽衍生配体NP30(1:Tyr-DAla-Gly-Phe-Gly-Trp-O-[3',5'-Bzl(CF3)2])合成并表征了几种双功能肽。对氨基酸残基进行了修饰和截短,并基于重叠药效团概念获得了三肽衍生配体NP66(11:Dmt-DAla-Trp-NH-[3',5'-(CF3)2-Bzl])。配体11的Trp(3)残基作为阿片样物质和NK1活性的信息残基。其意义在于观察到适当截短肽序列的方法可导致一种三肽衍生的嵌合配体,该配体对μ和δ阿片样物质受体以及NK1受体具有有效的结合和功能活性,分别对μ和δ阿片样物质受体具有激动剂活性,对NK1受体具有拮抗剂活性。

相似文献

1
Discovery of tripeptide-derived multifunctional ligands possessing delta/mu opioid receptor agonist and neurokinin 1 receptor antagonist activities.发现具有δ/μ阿片受体激动剂和神经激肽1受体拮抗剂活性的三肽衍生多功能配体。
Bioorg Med Chem Lett. 2015 Sep 1;25(17):3716-20. doi: 10.1016/j.bmcl.2015.06.030. Epub 2015 Jun 15.
2
Truncation of the peptide sequence in bifunctional ligands with mu and delta opioid receptor agonist and neurokinin 1 receptor antagonist activities.具有μ和 δ 阿片受体激动剂和神经激肽 1 受体拮抗剂活性的双功能配体中肽序列的截断。
Bioorg Med Chem Lett. 2013 Sep 1;23(17):4975-8. doi: 10.1016/j.bmcl.2013.06.065. Epub 2013 Jul 2.
3
Design, synthesis, and biological evaluation of novel bifunctional C-terminal-modified peptides for delta/mu opioid receptor agonists and neurokinin-1 receptor antagonists.新型双功能C末端修饰肽作为δ/μ阿片受体激动剂和神经激肽-1受体拮抗剂的设计、合成及生物学评价
J Med Chem. 2007 Jun 14;50(12):2779-86. doi: 10.1021/jm061369n. Epub 2007 May 22.
4
Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain.发现具有μ/δ阿片受体激动剂/神经激肽-1(NK1)拮抗剂活性的新型多功能配体用于疼痛治疗
J Med Chem. 2015 Nov 12;58(21):8573-83. doi: 10.1021/acs.jmedchem.5b01170. Epub 2015 Oct 30.
5
Discovery of a potent and efficacious peptide derivative for δ/μ opioid agonist/neurokinin 1 antagonist activity with a 2',6'-dimethyl-L-tyrosine: in vitro, in vivo, and NMR-based structural studies.发现一种强效、有效的肽衍生物,具有 δ/μ 阿片样物质激动剂/神经激肽 1 拮抗剂活性,具有 2',6'-二甲基-L-酪氨酸:体外、体内和基于 NMR 的结构研究。
J Med Chem. 2011 Apr 14;54(7):2029-38. doi: 10.1021/jm101023r. Epub 2011 Mar 2.
6
A structure-activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists.作为δ/μ阿片受体激动剂和神经激肽1受体拮抗剂的C末端修饰双功能肽的构效关系研究及组合合成方法
J Med Chem. 2008 Mar 13;51(5):1369-76. doi: 10.1021/jm070332f. Epub 2008 Feb 12.
7
The importance of micelle-bound states for the bioactivities of bifunctional peptide derivatives for delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists.胶束结合态对δ/μ阿片受体激动剂和神经激肽1受体拮抗剂双功能肽衍生物生物活性的重要性。
J Med Chem. 2008 Oct 23;51(20):6334-47. doi: 10.1021/jm800389v. Epub 2008 Sep 27.
8
Biological and conformational evaluation of bifunctional compounds for opioid receptor agonists and neurokinin 1 receptor antagonists possessing two penicillamines.具有两个青霉素胺的阿片受体激动剂和神经激肽 1 受体拮抗剂双功能化合物的生物学和构象评价。
J Med Chem. 2010 Aug 12;53(15):5491-501. doi: 10.1021/jm100157m.
9
Improving metabolic stability by glycosylation: bifunctional peptide derivatives that are opioid receptor agonists and neurokinin 1 receptor antagonists.通过糖基化提高代谢稳定性:阿片受体激动剂和神经激肽 1 受体拮抗剂的双功能肽衍生物。
J Med Chem. 2009 Aug 27;52(16):5164-75. doi: 10.1021/jm900473p.
10
Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties.Dmt-Tic药效团的评估:将一种强效δ-阿片受体拮抗剂转化为强效δ-激动剂以及具有混合性质的配体。
J Med Chem. 2002 Jan 31;45(3):713-20. doi: 10.1021/jm010449i.

引用本文的文献

1
Biphalin-A Potent Opioid Agonist-As a Panacea for Opioid System-Dependent Pathophysiological Diseases?脑啡肽-A 作为一种有效的阿片类激动剂——是否是治疗阿片类系统依赖的病理生理疾病的万灵药?
Int J Mol Sci. 2021 Oct 21;22(21):11347. doi: 10.3390/ijms222111347.
2
Harnessing the Anti-Nociceptive Potential of NK2 and NK3 Ligands in the Design of New Multifunctional μ/δ-Opioid Agonist-Neurokinin Antagonist Peptidomimetics.利用 NK2 和 NK3 配体的抗伤害感受潜力,设计新型多功能 μ/δ-阿片受体激动剂-神经激肽拮抗剂类肽。
Molecules. 2021 Sep 6;26(17):5406. doi: 10.3390/molecules26175406.
3
Synthesis and Pharmacological Evaluation of Hybrids Targeting Opioid and Neurokinin Receptors.靶向阿片类和神经激肽受体的杂合体的合成及药理学评价。
Molecules. 2019 Dec 5;24(24):4460. doi: 10.3390/molecules24244460.
4
Novel Pharmacological Nonopioid Therapies in Chronic Pain.慢性疼痛的新型药理学非阿片类治疗方法。
Curr Pain Headache Rep. 2018 Apr 3;22(4):31. doi: 10.1007/s11916-018-0674-8.
5
Neurokinin 1 and opioid receptors: relationships and interactions in nervous system.神经激肽1受体与阿片受体:神经系统中的关系及相互作用
Transl Perioper Pain Med. 2016;1(3):11-21.
6
Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain.用于治疗慢性疼痛的阿片类药物发现的新型分子策略与靶点
Yale J Biol Med. 2017 Mar 29;90(1):97-110. eCollection 2017 Mar.
7
Hydrazone Linker as a Useful Tool for Preparing Chimeric Peptide/Nonpeptide Bifunctional Compounds.腙连接体作为制备嵌合肽/非肽双功能化合物的有用工具。
ACS Med Chem Lett. 2016 Nov 1;8(1):73-77. doi: 10.1021/acsmedchemlett.6b00381. eCollection 2017 Jan 12.

本文引用的文献

1
Truncation of the peptide sequence in bifunctional ligands with mu and delta opioid receptor agonist and neurokinin 1 receptor antagonist activities.具有μ和 δ 阿片受体激动剂和神经激肽 1 受体拮抗剂活性的双功能配体中肽序列的截断。
Bioorg Med Chem Lett. 2013 Sep 1;23(17):4975-8. doi: 10.1016/j.bmcl.2013.06.065. Epub 2013 Jul 2.
2
Building a better analgesic: multifunctional compounds that address injury-induced pathology to enhance analgesic efficacy while eliminating unwanted side effects.构建更好的镇痛药:多功能化合物可解决损伤引起的病理变化,在提高镇痛疗效的同时消除不必要的副作用。
J Pharmacol Exp Ther. 2013 Oct;347(1):7-19. doi: 10.1124/jpet.113.205245. Epub 2013 Jul 16.
3
Design of novel neurokinin 1 receptor antagonists based on conformationally constrained aromatic amino acids and discovery of a potent chimeric opioid agonist-neurokinin 1 receptor antagonist.基于构象限制芳香族氨基酸的新型神经激肽 1 受体拮抗剂的设计和一种强效嵌合阿片类激动剂-神经激肽 1 受体拮抗剂的发现。
J Med Chem. 2011 Apr 14;54(7):2467-76. doi: 10.1021/jm1016285. Epub 2011 Mar 17.
4
Discovery of a potent and efficacious peptide derivative for δ/μ opioid agonist/neurokinin 1 antagonist activity with a 2',6'-dimethyl-L-tyrosine: in vitro, in vivo, and NMR-based structural studies.发现一种强效、有效的肽衍生物,具有 δ/μ 阿片样物质激动剂/神经激肽 1 拮抗剂活性,具有 2',6'-二甲基-L-酪氨酸:体外、体内和基于 NMR 的结构研究。
J Med Chem. 2011 Apr 14;54(7):2029-38. doi: 10.1021/jm101023r. Epub 2011 Mar 2.
5
Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance.脊髓或全身 TY005,一种肽类阿片激动剂/神经激肽 1 拮抗剂,可减轻疼痛并降低耐受性。
Br J Pharmacol. 2010 Nov;161(5):986-1001. doi: 10.1111/j.1476-5381.2010.00824.x.
6
Biological and conformational evaluation of bifunctional compounds for opioid receptor agonists and neurokinin 1 receptor antagonists possessing two penicillamines.具有两个青霉素胺的阿片受体激动剂和神经激肽 1 受体拮抗剂双功能化合物的生物学和构象评价。
J Med Chem. 2010 Aug 12;53(15):5491-501. doi: 10.1021/jm100157m.
7
Improving metabolic stability by glycosylation: bifunctional peptide derivatives that are opioid receptor agonists and neurokinin 1 receptor antagonists.通过糖基化提高代谢稳定性:阿片受体激动剂和神经激肽 1 受体拮抗剂的双功能肽衍生物。
J Med Chem. 2009 Aug 27;52(16):5164-75. doi: 10.1021/jm900473p.
8
Organic chemistry and biology: chemical biology through the eyes of collaboration.有机化学与生物学:合作视角下的化学生物学。
J Org Chem. 2009 Dec 18;74(24):9245-64. doi: 10.1021/jo901767e.
9
The biological activity and metabolic stability of peptidic bifunctional compounds that are opioid receptor agonists and neurokinin-1 receptor antagonists with a cystine moiety.具有二硫键的同时作为阿片受体激动剂和神经激肽-1 受体拮抗剂的肽类双功能化合物的生物活性和代谢稳定性。
Bioorg Med Chem. 2009 Oct 15;17(20):7337-43. doi: 10.1016/j.bmc.2009.08.035. Epub 2009 Aug 21.
10
Novel bifunctional peptides as opioid agonists and NK-1 antagonists.新型双功能肽作为阿片类激动剂和NK-1拮抗剂。
Adv Exp Med Biol. 2009;611:537-8. doi: 10.1007/978-0-387-73657-0_235.